Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Allannic

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA statusA M Madec, H Allannic, N Genetet, et al.
Diabetes & Metabolism|May 21, 1999
Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid diseaseD Maugendre, E Sonnet, C Derrien, et al.
La Revue De Medecine Interne|January 1, 1993
[Detection of subjects at risk of type 1 diabetes. GOFEDI. Groupe Ouest-France pour l'Etude du Diabète Insulino-dépendant]D Maugendre, S Bardet, V Rohmer, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Diabetologia|September 1, 1991
Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitusS Bardet, V Rohmer, D Maugendre, et al.
Acta Endocrinologica|January 1, 1983
Properdin factor B (Bf) and glyoxalase in Graves' diseaseH Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|May 26, 1999
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatmentD Maugendre, A Gatel, L Campion, et al.
La Revue De Medecine Interne|June 1, 1982
[Genetic factors Bf and glyoxalase in Basedow's disease]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 yearsS Bardet, V Rohmer, D Maugendre, et al.
Annales D'Endocrinologie|September 30, 1998
[Primary adrenal lymphoma with latent adrenal insufficiency: a case report and literature review]D Maugendre, C Derrien, I Grulois, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA statusA M Madec, H Allannic, N Genetet, et al.
Diabetes & Metabolism|May 21, 1999
Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid diseaseD Maugendre, E Sonnet, C Derrien, et al.
La Revue De Medecine Interne|January 1, 1993
[Detection of subjects at risk of type 1 diabetes. GOFEDI. Groupe Ouest-France pour l'Etude du Diabète Insulino-dépendant]D Maugendre, S Bardet, V Rohmer, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Diabetologia|September 1, 1991
Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitusS Bardet, V Rohmer, D Maugendre, et al.
Acta Endocrinologica|January 1, 1983
Properdin factor B (Bf) and glyoxalase in Graves' diseaseH Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|May 26, 1999
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatmentD Maugendre, A Gatel, L Campion, et al.
La Revue De Medecine Interne|June 1, 1982
[Genetic factors Bf and glyoxalase in Basedow's disease]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 yearsS Bardet, V Rohmer, D Maugendre, et al.
Annales D'Endocrinologie|September 30, 1998
[Primary adrenal lymphoma with latent adrenal insufficiency: a case report and literature review]D Maugendre, C Derrien, I Grulois, et al.
Pageof 10